The North America oxygen concentrators market size was estimated at USD 2.21 Billion in 2025 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 10.0% from 2025 to 2033. The growth is attributed to an increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
According to the 2024 National Survey by Asthma Canada, over 4.6 million people in Canada are living with asthma, including 900,000 children under 19 and 800,000 adults over 65. Asthma is the third most prevalent chronic disease in the country, with an estimated 317 new diagnoses every day and around 250 deaths annually. In addition, advancements in respiratory technology are significantly supporting market growth.
Furthermore, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in North America. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. and Canada is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.
Initiatives by public and private authorities, such as the World Health Organization's distribution of oxygen concentrators and the efforts of associations like the American Lung Association, promote awareness of respiratory diseases. Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features a compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.
This product will be delivered within 1-3 business days.
According to the 2024 National Survey by Asthma Canada, over 4.6 million people in Canada are living with asthma, including 900,000 children under 19 and 800,000 adults over 65. Asthma is the third most prevalent chronic disease in the country, with an estimated 317 new diagnoses every day and around 250 deaths annually. In addition, advancements in respiratory technology are significantly supporting market growth.
Furthermore, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in North America. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. and Canada is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.
Initiatives by public and private authorities, such as the World Health Organization's distribution of oxygen concentrators and the efforts of associations like the American Lung Association, promote awareness of respiratory diseases. Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features a compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.
North America Oxygen Concentrator Market Report Segmentation
This report forecasts volume & revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the North America oxygen concentrator market report on the basis of product, application, technology, and country.- Products Outlook (Volume, Unit 000'; Revenue, USD Million, 2021-2033)
- Portable Medical Oxygen Concentrators
- Fixed Medical Oxygen Concentrators
- Application Outlook (Volume, Unit 000'; Revenue, USD Million, 2021-2033)
- Home Care
- Non-home Care
- Technology Outlook (Volume, Unit 000'; Revenue, USD Million, 2021-2033)
- Continuous Flow
- Pulse Flow
- Country Outlook (Volume, Unit 000'; Revenue, USD Million, 2021-2033)
- U.S
- Canada
- Mexico
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. North America Oxygen Concentrator Systems Market: Products Estimates & Trend Analysis
Chapter 5. North America Oxygen Concentrator Market: Application Estimates & Trend Analysis
Chapter 6. North America Oxygen Concentrator Market: Technology Estimates & Trend Analysis
Chapter 7. North America Oxygen Concentrator Market: Country Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this North America Oxygen Concentrators market report include:- Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
- Direct Supply
- GF Health Products, Inc.
- MedaCure Inc.
- Nidek Medical Products, Inc
- O2 Concepts
- React Health
- CAIRE Inc. (Acquired by Niterra Co., Ltd., formerly known as NGK SPARK PLUG CO., LTD.)
- DeVilbiss Healthcare (a subsidiary of Drive Medical)
- GCE Group
- Compass Health Brands
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 2.21 Billion |
| Forecasted Market Value ( USD | $ 4.72 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | North America |
| No. of Companies Mentioned | 11 |
